The industry-academia partnership will start out with collaborations in the healthcare, robotics and human resources spaces, including a sports science tie-up with a Rakuten-owned baseball team and plans for software development hackathons.

NextGen Jane, which is looking to commercialise reproductive health technology partially developed at Harvard, has received $9m from investors including Harvard-affiliated backers.

Varian led a round for the targeted cancer drug developer that included fellow existing investors including Johnson & Johnson and Pivotal BioVenture Partners.

The healthcare management software producer received $74m in a series C round backed by China Pacific Insurance and will use the cash for product development.

Sofinnova Investments added $12m to a series B round backed by PureTech Health and Pivotal BioVenture Partners that has now closed at $80m.

The digital prescription platform's series A round included McKesson Ventures, Novartis, Philips, ResMed, Providence Ventures, UPMC and Froedtert and the Medical College of Wisconsin.

University of Michigan critical care monitoring technology spinout Fifth Eye has collected series A funding from investors including the university's Mints fund.

Pfizer spinoff Springworks has followed up its $103m series A round two years back by adding $125m in a round that also included GlaxoSmithKline.

The healthcare insurance and financing platform secured $74.3m in a Tencent-led series B round that will fund hiring and AI technology development.

Corporate venturing units Kamet Ventures and Dell Technologies Capital both contributed to a round that will fund the growth of Ibex Medical Analytics' team.